FIELD: chemistry.
SUBSTANCE: present invention relates to novel hydantoin derivatives of formula or pharmaceutically acceptable salt thereof, where R1 is H, halogen, CF3 or CH2CN; R2 is C1-3alkyl; each of A, A1 and B independently represents CH or N. The invention also relates to a method for synthesis of a formula I compound, to a pharmaceutical composition based a formula I compound and use thereof in making a medicinal agent.
EFFECT: obtaining novel hydantoin derivatives with inhibitory activity towards metalloproteinase.
10 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
NEW DERIVATIVES OF HYDANTOIN AS INHIBITORS OF METAL PROTEINASES | 2005 |
|
RU2376301C2 |
NEW HYDANTOIC DERIVATIVES FOR TREATING OBSTRUCTIVE AIRWAY DISEASES | 2005 |
|
RU2386629C2 |
HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2018 |
|
RU2797822C2 |
HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS | 2007 |
|
RU2463301C2 |
INHIBITORS OF METALLOPROTEINASES, THEIR USING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2288228C2 |
HETEROCYCLIC COMPOUNDS AND METHODS OF APPLICATION | 2009 |
|
RU2525116C2 |
SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
SUBSTITUTED 1,2-DIHYDRO[2,7]NAPHTHIRIDINES, PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND APPLYING | 2003 |
|
RU2243218C1 |
COMPOUNDS AND METHODS FOR USING | 2009 |
|
RU2561109C2 |
BICYCLIC CONDENSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS | 2016 |
|
RU2684324C1 |
Authors
Dates
2010-01-10—Published
2005-12-14—Filed